Career history of Saeed Motahari
Former positions of Saeed Motahari
| Companies | Position | Start | End |
|---|---|---|---|
| INSYS THERAPEUTICS, INC. | Director/Board Member | 2017-04-16 | 2019-04-13 |
| Chief Executive Officer | 2017-04-16 | 2019-04-13 | |
| President | 2017-04-16 | 2019-04-13 | |
| ABBVIE INC. | Corporate Officer/Principal | - | - |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | 2014-05-21 | - |
Training of Saeed Motahari
| Concordia University | Graduate Degree |
Statistics
International
| United States | 4 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Private companies | 2 |
|---|---|
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
INSYS Therapeutics, Inc.
 INSYS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ. | Health Technology |
- Stock Market
- Insiders
- Saeed Motahari
- Experience
